ondansetron has been researched along with Heroin Abuse in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Excerpt | Relevance | Reference |
---|---|---|
"Withdrawal symptoms were still present 24 h after detoxification and 80% of the patients relapsed during a 6-month follow-up." | 1.30 | Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results. ( Bertschy, G; Cucchia, AT; Ferrero, F; Monnat, M; Spagnoli, J, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Loimer, N | 1 |
Hofmann, P | 1 |
Chaudhry, H | 1 |
Cucchia, AT | 1 |
Monnat, M | 1 |
Spagnoli, J | 1 |
Ferrero, F | 1 |
Bertschy, G | 1 |
2 other studies available for ondansetron and Heroin Abuse
Article | Year |
---|---|
Ultrashort noninvasive opiate detoxification.
Topics: Adult; Heroin Dependence; Humans; Male; Midazolam; Naloxone; Naltrexone; Ondansetron; Substance With | 1993 |
Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results.
Topics: Administration, Oral; Adolescent; Adult; Anesthesia, General; Clonidine; Drug Therapy, Combination; | 1998 |